Company page
Prothena Corporation Plc
Prothena Corporation Plc is a public company traded under the ticker PRTA in the American market. The company has a market capitalization of approximately $458 million. Prothena focuses on developing transformative therapies for diseases with high unmet medical needs.
- Ticker
- PRTA:NASDAQ
- Asset type
- Stock
- Market cap
- $458.4M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD